
Global Organ Preservation Solutions Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Organ Preservation Solutions market size will reach US$ 291 million by 2031.
United States market for Organ Preservation Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Organ Preservation Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Organ Preservation Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Organ Preservation Solutions players cover Dr. Franz Köhler Chemie, Teva Pharmaceutical Industries Ltd., Lifeline Scientific, Bristol-Myers Squibb, BioLife Solutions, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Organ Preservation Solutions Industry Forecast” looks at past sales and reviews total world Organ Preservation Solutions sales in 2024, providing a comprehensive analysis by region and market sector of projected Organ Preservation Solutions sales for 2025 through 2031. With Organ Preservation Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Organ Preservation Solutions industry.
This Insight Report provides a comprehensive analysis of the global Organ Preservation Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Organ Preservation Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Organ Preservation Solutions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Organ Preservation Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Organ Preservation Solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Organ Preservation Solutions market by product type, application, key players and key regions and countries.
Segmentation by Type:
Viaspan
Custodial
siRNA Transplant Solutions
Others
Segmentation by Application:
Hypothermic Perfusion Preservation (HPP)
Static Cold Storage (SCS)
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Dr. Franz Köhler Chemie
Teva Pharmaceutical Industries Ltd.
Lifeline Scientific
Bristol-Myers Squibb
BioLife Solutions, Inc.
XVIVO Perfusion AB
ToleroTech, Inc
CryoLife, Inc.
Claris Lifesciences Limited
BioTime, Inc.
21st Century Medicine
Please note: The report will take approximately 2 business days to prepare and deliver.
United States market for Organ Preservation Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Organ Preservation Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Organ Preservation Solutions is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Organ Preservation Solutions players cover Dr. Franz Köhler Chemie, Teva Pharmaceutical Industries Ltd., Lifeline Scientific, Bristol-Myers Squibb, BioLife Solutions, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Organ Preservation Solutions Industry Forecast” looks at past sales and reviews total world Organ Preservation Solutions sales in 2024, providing a comprehensive analysis by region and market sector of projected Organ Preservation Solutions sales for 2025 through 2031. With Organ Preservation Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Organ Preservation Solutions industry.
This Insight Report provides a comprehensive analysis of the global Organ Preservation Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Organ Preservation Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Organ Preservation Solutions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Organ Preservation Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Organ Preservation Solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Organ Preservation Solutions market by product type, application, key players and key regions and countries.
Segmentation by Type:
Viaspan
Custodial
siRNA Transplant Solutions
Others
Segmentation by Application:
Hypothermic Perfusion Preservation (HPP)
Static Cold Storage (SCS)
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Dr. Franz Köhler Chemie
Teva Pharmaceutical Industries Ltd.
Lifeline Scientific
Bristol-Myers Squibb
BioLife Solutions, Inc.
XVIVO Perfusion AB
ToleroTech, Inc
CryoLife, Inc.
Claris Lifesciences Limited
BioTime, Inc.
21st Century Medicine
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
119 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Organ Preservation Solutions Market Size by Player
- 4 Organ Preservation Solutions by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Organ Preservation Solutions Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.